Currently, Dr. Harch performs consultations on any patient seeking HBOT for any indication, “accepted” or off-label. Symposium on Cerebral Palsy and the Brain Injured Child; July 2003, Fort Lauderdale, Florida, USA, Update on the ongoing “UDAAN” Multimode, including Hyperbaric Oxygenation and Early Medical Intervention Therapy for small children with Cerebral Palsy, Paper presented at 4th Int. He has worked significantly on the health problems of tribal communities in India, including those of Andaman islands. The business model of Udaan is to provide a platform for retailers, wholesalers etc. The annual revenue of the company is estimated to be $4M. We aim to setup this dedicated institute for the Divyang/differentially abled persons/Children. Dr. Marois has specific expertise in the oxygenation process, having been one of the leaders of a research team involved in oxygenation projects from 1998-2001 for which he received the inaugural Richard A. Neubauer award. Since HBOT is a drug, proper dosing is necessary to avoid toxicity that has been identified by Dr. Harch’s research and clinical practice. He is our legal adivisor, takes a keen interest in our activities and guides us in maintaining our aims and objectives in serving the cause of brain damaged children. He is the Editor-in-Chief of Indian Journal of Pediatrics, which is the oldest speciality journal in India. Dr Pierre Marois is a pediatric physiatrist working at Ste-Justine University Hospital (Montreal), as well as in many rehabilitation centers in the province of Quebec, for the past 25 years. J. Michael Uszler, M.D. Read more about Udaan co-founders on how their set up earned the fast-growing unicorn tag on Business Standard. His clinical and research interests are in the management of fetal medicine and reproductive genetics, dysmorphology, genetic counseling and prenatal diagnosis using molecular, cytogenetic and biochemical techniques. We have come up again with a new model for Early Years development for children with special needs. Indian Pioneer of Multimode Dan Protocol & HBOT Based Management of children with Autism in my capacity of Director, Autism Research Project, at UDAAN. Udaan’s mobile app connects nearly 150,000 traders, retailers, wholesalers in India. Brief Profile : Manage all types of paediatric emergencies, including pre-mature babies in nursery. He is the Editor-in-Chief of Indian Journal of Pediatrics, which is the oldest speciality journal in India. As a board certified Nuclear Medicine physician he has 3 decades of academic and clinical experience in hospital-based care, including 8 years at UCLA-Harbor General Hospital, 20 years as Medical Director of Nuclear Medicine at Santa Monica Hospital, and now at Saint Johns Health Center in Santa Monica, as well as in private practice. Chief Investigator, Double Blind Placebo Controlled Randomized Clinical Trial of Vitamin MB12 in Autism, (Study approved by Drugs Controller of India), To see the effect of Hyperbaric Oxygen Therapy in Gross Motor Abilities of cerebral palsy Children of 2-5 years, given initially as an adjunct to Occupational Therapy; Ind. Indian Pioneer of Multimode Dan Protocol & HBOT Based Management of children with Autism in my capacity of Director, Autism Research Project, at UDAAN. He is nationally recognized for his expertise of brain SPECT imaging of disorders such as Autistic Spectrum Disorders, Cerebral Palsy, ADD/ADHD, near-drowning, closed head trauma, toxic encephalopathy, stroke and dementia, and in using SPECT and PET brain function imaging to follow the effectiveness of various therapies of these conditions, particularly Hyperbaric Oxygen Therapy.